MetaCap

Pacira BioSciences Insider Trades

NASDAQ: PCRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

36.31-0.08 (-0.22%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
1 · $217.92K
Shares bought / sold
0 / 6.00K
Net activity
Net selling $217,920

Pacira BioSciences insider activity

Over the last 12 months, Pacira BioSciences insiders reported 2 transactions on SEC Form 4: 0 open-market purchases and 1 sale. Insiders bought $0 and sold $217,920 worth of stock, for net insider selling of $217,920. The largest seller was RIKER LAUREN, with $217,920 in reported sales.

The most recent filing shows RIKER LAUREN (Senior Vice President, Finance) reporting a transaction in 6,000 shares at $32.35 on Oct 8, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put PCRX's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

PCRX insider transactions

Pacira BioSciences insider transactions
DateInsiderTypeSharesValueFiling
Oct 8, 2026RIKER LAURENSenior Vice President, FinanceSale6,000$217.92KForm 4
Oct 8, 2026RIKER LAURENSenior Vice President, FinanceOption exercise6,000$194.10KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related